Chugai Pharmaceutical Co. Ltd.
CHGCY | OTC
$21
-$0.46 (-2.14%)
At close: Sep 24, 2026, 3:59 PM ET
$21.03
+$0.03 (+0.14%)
After-hours:
Sep 24, 2026, 3:57 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 116.33B | 115.42B | 128.41B | 111.21B | 97.16B | 97.23B | 91.56B | 109.5B | 111.86B | 74.4B | 91.21B | 120.03B | 112.7B | 112.28B | 161.71B | 106.13B | 108.37B | 199.66B | 98.84B | 133.22B | 70.73B | 73.52B |
Depreciation & Amortization | n/a | 8.8B | 11.9B | 19.8B | 400M | 400M | 30.47B | 400M | 400M | 400M | 1.6B | 300M | 400M | 500M | 600M | 500M | 300M | 300M | 30.87B | 400M | 1.2B | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -44.22B | 56.66B | -62.15B | -33.58B | -24.68B | 40.76B | 9.17B | 28.95B | -111.07B | 44.11B | 12.76B | -11.69B | 5.38B | 124.19B | -198.86B | -6.56B | 55.26B | -33.16B | -61.63B | -8.6B | -53.06B | 40.17B |
Other Non-Cash Items | 55.94B | -57.47B | 51.88B | -25.36B | 47.12B | -71.05B | 21.2B | -14.48B | 69.46B | -18B | 19B | -77.34B | 8.2B | -109.23B | 9.54B | -74.88B | 9.45B | -94.26B | 26.88B | -43.36B | 37.59B | -67.14B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -44.22B | 56.66B | -62.15B | -33.58B | -24.68B | 40.76B | 9.17B | 28.95B | -111.07B | 44.11B | 12.76B | -11.69B | 5.38B | 124.19B | -198.86B | -6.56B | 55.26B | -33.16B | -61.63B | -8.6B | -53.06B | 40.17B |
Operating Cash Flow | 128.05B | 123.4B | 130.04B | 72.07B | 120B | 67.34B | 152.39B | 124.37B | 70.65B | 100.91B | 124.56B | 31.3B | 126.67B | 127.75B | -27B | 25.19B | 173.39B | 72.54B | 94.96B | 81.67B | 56.46B | 46.54B |
Capital Expenditures | -8.59B | -12.7B | -17.37B | -9.98B | -26.82B | -22.1B | -316M | -17.52B | -20.49B | -12.53B | -18.22B | -9.37B | -19.48B | -27.19B | -12.01B | -8.92B | -13.53B | -36.79B | -7.85B | -25.15B | -7.97B | -31.89B |
Cash Acquisitions | n/a | n/a | 224M | -72M | 7.36B | n/a | n/a | n/a | n/a | n/a | 17.36B | 53M | -318M | 1.7B | -83M | -24M | 1.16B | n/a | -21M | 2.43B | 1.5B | 2.95B |
Purchase of Investments | -330.37B | -260.47B | -332.98B | -306.04B | -272.69B | -320.06B | -222.28B | -246.07B | -290.16B | -190.05B | -125.8B | -136.45B | -117.07B | -166.66B | -125.01B | -163.76B | -110.2B | -120.04B | -94.34B | -85.04B | -82.83B | -110.06B |
Sales Maturities Of Investments | 190B | 393.32B | 205.33B | 410B | 260.63B | 255B | 205.63B | 225.3B | 170.61B | 169.48B | 131.87B | 147.31B | 125.88B | 141.9B | 115B | 125.15B | 80B | 122.77B | 85.03B | 85B | 60B | 95B |
Other Investing Acitivies | 14M | n/a | n/a | 1M | -1M | 29M | 582M | 1.16B | 1.15B | 857M | 3M | 450M | 1.44B | 14.88B | 85M | 94M | 28M | 73M | 16M | -2.41B | -397M | -2.89B |
Investing Cash Flow | -150.97B | 112.29B | -162.8B | 92.82B | -47.29B | -87.6B | -17.5B | -38.3B | -140.65B | -32.24B | 5.21B | 1.99B | -9.56B | -35.37B | -22.02B | -47.45B | -42.55B | -33.98B | -17.17B | -25.17B | -29.7B | -46.9B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | -2.03B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -3.93B | -2M | -3M | -1M | -1M | -1M | -1M | -4M | -2M | -3M | -2M | -1M | -1M | -1M | -1M | -1M | -2M | -1M | -1M | -1M | -2M | -4M |
Dividend Paid | 65M | -241.99B | 123M | -205.7B | -438M | -93.41B | -290M | -67.46B | -540M | -64.96B | -368M | -65.41B | -452M | -65.37B | -422M | -62.06B | -581M | -75.16B | -320M | -49.01B | -263M | -49.05B |
Other Financial Acitivies | -2.28B | -2.51B | -2.24B | -1.98B | -1.92B | 1M | -1.66B | -2.1B | -2.07B | -1.98B | -1.9B | -1.99B | -1.95B | -2.04B | -1.94B | -1.95B | -1.91B | -1.86B | -2.72B | -2.07B | -2.06B | -2.23B |
Financial Cash Flow | -6.15B | -244.44B | -2.11B | -207.67B | -2.35B | -95.33B | -1.94B | -69.51B | -2.6B | -66.87B | -2.22B | -67.38B | -2.37B | -67.28B | -2.36B | -63.98B | -2.44B | -76.87B | -2.98B | -51.04B | -2.26B | -51.12B |
Net Cash Flow | -27.55B | -8.62B | -29.83B | -40.66B | 73.67B | -116.78B | 136.24B | 10.2B | -69.1B | 4.19B | 127.33B | -33.68B | 117.33B | 25.52B | -51.87B | -86.27B | 129.84B | -37.28B | 75.24B | 5.39B | 25.08B | -50.28B |
Free Cash Flow | 119.46B | 110.71B | 112.67B | 62.1B | 93.17B | 45.24B | 152.08B | 106.85B | 50.16B | 88.38B | 106.35B | 21.93B | 107.19B | 100.56B | -39.01B | 16.27B | 159.86B | 35.75B | 87.11B | 56.52B | 48.49B | 14.65B |
Adj. Free Cash Flow | 119.46B | 110.71B | 112.67B | 62.1B | 93.17B | 45.24B | 152.08B | 106.85B | 50.16B | 88.38B | 106.35B | 21.93B | 107.19B | 100.56B | -39.01B | 16.27B | 159.86B | 35.75B | 87.11B | 56.52B | 48.49B | 14.65B |
Maintenance CapEx | n/a | -8.8B | -1.3B | -3.62B | -26.82B | -3.38B | n/a | n/a | -2.95B | -12.53B | -18.22B | n/a | -8.19B | -11.7B | n/a | -8.92B | -8.6B | -2.15B | n/a | n/a | n/a | -31.89B |
Growth CapEx | -8.59B | -3.9B | -16.07B | -6.36B | n/a | -18.72B | -316M | -17.52B | -17.55B | n/a | n/a | -9.37B | -11.3B | -15.49B | -12.01B | n/a | -4.93B | -34.64B | -7.85B | -25.15B | -7.97B | n/a |
Owner Earnings | 128.05B | 114.6B | 128.75B | 68.45B | 93.17B | 63.96B | 152.39B | 124.37B | 67.7B | 88.38B | 106.35B | 31.3B | 118.49B | 116.04B | -27B | 16.27B | 164.79B | 70.39B | 94.96B | 81.67B | 56.46B | 14.65B |
Add to Watchlist
Select watchlists to add or remove CHGCY